Pfizer says COVID-19 jab could rake in $26bn this yearPfizer expects revenues from its BioNTech-partnered COVID-19 vaccine to reach an eye-watering $26 billion this year, catapulting it Share XPfizer says COVID-19 jab could rake in $26bn this yearhttps://pharmaphorum.com/news/pfizer-says-covid-19-jab-could-rake-in-26bn-this-year/
EU starts rolling review of Sinovac’s COVID-19 vaccineEurope’s regulator has begun a rolling review of Sinovac’s COVID-19 vaccine, known as Vero Cell. The vaccine is Share XEU starts rolling review of Sinovac’s COVID-19 vaccinehttps://pharmaphorum.com/news/eu-regulator-begins-review-of-sinovacs-covid-19-vaccine/
Vicore signs deal with Alex to develop digital therapeutic to support IPF patientsRare disease specialist Vicore Pharma has signed an agreement with Alex Therapeutics to test a digital therapeutic designed Share XVicore signs deal with Alex to develop digital therapeutic to support IPF patientshttps://pharmaphorum.com/news/vicore-signs-deal-with-alex-to-develop-digital-therapeutic-to-support-ipf-patients/
MoonLake launches, licensing in Merck KGaA’s Cosentyx challenger sonelokimabThere’s a new biotech on the scene after MoonLake Immunotherapeutics launched on a mission to develop sonelokimab, a Share XMoonLake launches, licensing in Merck KGaA’s Cosentyx challenger sonelokimabhttps://pharmaphorum.com/news/moonlake-launches-licensing-in-merck-kgaas-cosentyx-challenger-sonelokimab/
AstraZeneca’s Farxiga claims first SGLT2 kidney disease OK from FDAAstraZeneca is already seeing sales rocket for its SGLT2 inhibitor Farxiga in heart failure, and is expected to Share XAstraZeneca’s Farxiga claims first SGLT2 kidney disease OK from FDAhttps://pharmaphorum.com/news/astrazenecas-farxiga-gets-first-kidney-disease-ok-from-fda/
Janssen files its first CAR-T therapy cilta-cel in EuropeJohnson & Johnson’s Janssen unit has filed for approval of its multiple myeloma CAR-T ciltacabtagene autoleucel in Europe, Share XJanssen files its first CAR-T therapy cilta-cel in Europehttps://pharmaphorum.com/news/janssen-files-its-first-car-t-therapy-cilta-cel-in-europe/
Langland appoints Mike Brightley as advertising creative directorLangland has appointed Mike Brightley as creative director for its advertising section. Brightley has more than 14 years Share XLangland appoints Mike Brightley as advertising creative directorhttps://pharmaphorum.com/news/langland-appoints-mike-brightley-as-advertising-creative-director/
Dentsu launches global healthcare agency dentsu healthDentsu International has announced the launch of a global healthcare agency dentsu health. The New York-based marketing firm Share XDentsu launches global healthcare agency dentsu healthhttps://pharmaphorum.com/news/dentsu-launches-global-healthcare-agency-dentsu-health/
NHS app could be used as a vaccine passportThe NHS app could be used a kind of vaccine passport, according to UK government sources, although it Share XNHS app could be used as a vaccine passporthttps://pharmaphorum.com/news/nhs-app-could-be-used-as-a-vaccine-passport/
